The Scavdis Group Advantage
Unparalleled Federal Investigation Experience
George Scavdis brings 22 years of federal criminal investigation experience across multiple agencies, with 16 years specifically focused on FDA's Office of Criminal Investigations. As Special Agent in Charge, he led multi-state operations covering eight states plus the District of Columbia, supervising over 30 investigators and analysts while managing the most complex and high-profile cases in FDA's portfolio. His credentials include a law degree from Case Western Reserve University, a certification by the Federal Law Enforcement Training Center, and Top Secret/SCI security clearance, which has provided him with the legal acumen and investigative expertise that corporate investigations demand.
FDA Leadership Credentials
In his role as Special Agent in Charge of the Metro Washington Field Office, George personally reviewed every False Claims Act complaint filed in federal court involving FDA products, making preliminary assessments and assigning them for investigation when appropriate. He conducted weekly meetings with FDA General Counsel on criminal investigations and served as direct FDA liaison with U.S. Attorney's Offices, DOJ Consumer Protection Branch, and DOJ Civil Frauds. This key role in FDA allowed George to set investigative priorities for entire regions in the U.S. market based on public health impact, giving him unmatched insight into enforcement strategies and regulatory concerns.
Proven Track Record with Multi-Million Dollar Cases
George served as lead FDA case agent on the highly publicized Theranos investigation involving Elizabeth Holmes and Ramesh "Sunny" Balwani, which resulted in Holmes receiving an 11-year prison sentence and Balwani receiving 13 years for defrauding investors out of hundreds of millions of dollars. Both defendants ordered to pay $452 million in restitution. George also led government investigations resulting in major corporate settlements, including the Biocompatibles medical device case that yielded a $36 million settlement and the OtisMed investigation that produced an $80 million resolution with the CEO sentenced to 24 months in prison. These high-profile case results demonstrate his ability to navigate complex issues in corporate fraud cases from initial assessment of whistleblower allegations through investigation and successful criminal and civil resolution.
Internal Affairs Expertise
As Special Agent in Charge of FDA's Office of Internal Affairs, George investigated employee misconduct, conflicts of interest, and trade secret theft while reporting directly to FDA senior executives. His many accomplishments in this role included completely revamping the office's written reports of investigation, transforming them from simple fact recitations to comprehensive analytical assessments that included legal conclusions and specific remediation recommendations. His expertise encompasses cyber-physical security, document and data theft, unauthorized disclosures, and the intersection of employee misconduct with corporate liability.
Investigative Excellence at Federal Standards
George completed FDA's Drug Investigator Training Program and possesses advanced interview and interrogation techniques that were proven effective under close examination in federal court proceedings. His investigations utilized sophisticated digital forensics and document analysis capabilities, along with access to federal databases and investigative resources that corporate investigators cannot match. Most importantly, his documentation consistently withstood prosecutorial and regulatory scrutiny, ensuring that investigation findings were accepted and respected by enforcement agencies.